Woman and Man
- | Country :
- France
- | organs : -
- | Specialty : -
Extract
Lenakap : This multicenter, non randomized (single arm), open, phase II study aims to evaluated the efficacy of Lenalidomide in HIV-associated kaposi disease. Patients will be followed for 48 weeks. Measurement of primary endpoint will be at 24 weeks.
Inclusion criteria
- HIV Infection Associated Kaposi Disease